Laboratory Considerations for Clinical Trials
Kanal-Details
Laboratory Considerations for Clinical Trials
This podcast from IQVIA Laboratories looks at factors sponsors should consider when preparing for clinical trials.
Neueste Episoden
25 Episoden
What is the Role of Digital Pathology in Clinical Trials
In this episode, Dr. Monika Lamba, a pathologist from Q² Solutions, discusses the transformative role of digital pathology in clinical trials. Despite...
AI in Pathology: Advancements, Challenges, and the Road Ahead
In this episode Dr. Monika Lamba Saini and Bruno Larvol of “LARVOL & Friends” discuss the role of artificial intelligence (AI) in pathology and its po...
Flow Cytometry as an IVD technology for Companion Diagnostics
In this episode, Megan McCausland, Scientific Advisor for Flow Cytometry at Q2 Solutions, and Scott Bornheimer, Associate Director of Medical and Scie...
Flexible Approaches for Biotech Companies in Clinical Trials
With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech com...
Risk Management for Biotech Companies in Clinical Trials
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how...
3 Things to Consider in Preparation for Your Biotech Testing or Trial
Alex Watt is the Global Head for Biotech Integrated Laboratory Solutions at Q2 Solutions. In this episode, the first of a three-part series, he talks...
Hybrid assays: an interview with Barry Jones and Adriane Spytko
Becoming bilingual in bioanalysis
In this podcast Barry Jones (Director, LC–MS Biologics and Biomarkers at Q² Solutions) and Adriane Spyt...
Managing Sample Data from Vendors
Most clinical trials involve a variety of laboratory vendors and CROs to provide services during the course of the study. Disparity in how each vendor...
Automation within an ADME Laboratory
Taking an assay from bench to an automated platform
In this podcast, Prakash Bhosale (Director of Discovery ADME at Q2 Solutions; IN, USA) discu...
Bioanalytical Automation of Samples
In this podcast interview, Jason Evans (Scientist at Q² Solutions) discusses the importance of automation and key advantages of taking an assay from t...
Consent Tracking for Clinical Samples
Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential...
Tracking Clinical Trial Samples
The clinical trial ecosystem is a complex web of investigator sites, laboratories, couriers, patient samples and more. The ability to track those sam...
Avoiding Canceled Tests in Pediatric Samples
In this episode, Charlie Fix, Global Director of Scientific Harmonization for Q Squared Solutions describes the challenges of safety testing for drugs...
Covid Vaccine Testing
In this episode, Dr. Robert Bailer, Senior Director for Vaccines at Q2 Solutions, describes the processes for testing vaccines against the novel coron...
Hybrid Assays for Protein Bioanalysis
In this episode, Drs. Steven Lowes and Barry Jones discuss hybrid assays, combining immuno-affinity with liquid chromatography-mass spectrometry (LC-M...
High Throughput ADME Testing
ADME testing (Absorption, Distribution, Metabolism and Excretion) is an essential part of early stage drug development. In this episode, Dr. Matt Hut...
Liquid Biopsy Collection in Clinical Development Programs
A liquid biopsy is a minimally invasive alternative to a more traditional surgical solid tumor biopsy.
In this episode, Dr. Stephanie Hastings,...
An Next Generation Sequencing Approach to Influenza Vaccine Development
In this episode, Dr. Wayne Hogrefe and Dr. Pat Hurban discuss the use of NGS in the development and assessment of new vaccines against the influenza v...
Standardization of Tumor Mutational Burden by Alignment to Reference Standards
In this episode, Victor Weigman, Director of Translational Genomics at Q Squared Solutions and Mark Stewart, Vice President of Science Policy at Frien...
Monitoring the Tumor Micro-environment with Flow Cytometry - Mark Edinger
Mark Edinger is the Scientific Advisor for Flow Cytometry at Q2 Solutions. In this episode, he describes recent advances in flow cytometry and what th...
Companion Diagnostic Strategies for Commercial Success
In this episode, he describes strategies for mitigating risk in the development of companion diagnostics (CDx) for immuno-oncology.
Depending on...
The Role of Genomics in Clinical Trials for Immuno-oncology - Dr. Patrick Hurban
Genomics has come a long way from the days of being primarily a discovery tool.
It used be that essentially all of the genomic data that was bei...
Bioanalysis for Immuno-oncology - Dr. Mike Brown
Mike Brown is the Senior Director of Immuno-analytical and the Bioanalytical Site Lead at Q2 Solutions. In this episode, he describes the consideratio...
Anatomic Pathology
In this episode, Dr. Radha Krishnan describes three key challenges in immuno-oncology development related to anatomic pathology. Some of the key chall...
Selection of Biomarkers for Immuno-Oncology - Patrice Hugo
Dr. Patrice Hugo, Chief Scientific Advisor at Q2 Solutions discusses the selection and use of biomarkers in Immuno-oncology trials and the importance...